Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
With a market cap of 138.21B, Pfizer(PFE) trades at $24.30. The stock has a price-to-earnings ratio of 18.59 and currently yields dividends of 7.09%.
During the trading session on 2026-07-10, Pfizer(PFE) shares reached a daily high of $24.30 and a low of $24.01. At a current price of $24.30, the stock is +1.2% higher than the low and still -0.0% under the high.
Trading volume for Pfizer(PFE) stock has reached 29.19M, versus its average volume of 49.81M.
The stock's 52-week range extends from a low of $23.11 to a high of $28.75.
The stock's 52-week range extends from a low of $23.11 to a high of $28.75.
PFE News
Transformative AI in healthcare sits at the crossroads of powerful themes investors are watching today: pressure to improve efficiency, closer scrutiny on costs...
A U.S. appeals court on Thursday upheld a ruling for AstraZeneca (AZN) against allegations that its blockbuster lung-cancer drug Tagrisso infringed patents owne...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more c...
Analyst ratings
62%
of 29 ratingsMore PFE News
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more c...
‘It Kills Me to Say That’: Cramer Won’t Recommend Pfizer, Even With Its 7% Dividend By Danielle Liverance Published Jul 9, 12:25PM EDT Quick Read Cramer passe...
Advertisement FDA approval and dividend move put Pfizer in focus Pfizer (PFE) has drawn fresh attention after the FDA approved a new maintenance use for IBRAN...
JPMorgan lowered the firm’s price target on Pfizer (PFE) to $28 from $30 and keeps a Neutral rating on the shares. Unlock powerful investing tools and data-dri...
Biotech and Pharma Former Pfizer Building Is Crumbling—Just as the Stock Has In this article PFE SPX LLY BNTX Workers at the former Pfizer headquarters were eva...
Pfizer (PFE) stock was recovering on Tuesday after a top Wall Street analyst hit the pharmaceutical company’s shares with a downgrade. Four-star HSBC analyst Ra...
It's hard not to love high dividend yields. Who doesn't want more dividends for their money? Pfizer (PFE +1.62%) and its current yield of 7% will certainly grab...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.